Latest Articles

Publication Date
Gesynta Pharma reaches 50% patient enrollment milestone in Phase 2 endometriosis trial - Vietnam Investment Review - VIR

Gesynta Pharma reaches 50% patient enrollment milestone in Phase 2 endometriosis trial Vietnam Investment Review - VIR

Published: June 18, 2026, 8:05 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - Macau Business

Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat Macau Business

Published: June 18, 2026, 7:26 a.m.
Awareness gap linked to years-long diagnostic delays for endometriosis patients - b2bnews.co.nz

Awareness gap linked to years-long diagnostic delays for endometriosis patients b2bnews.co.nz

Published: June 18, 2026, 5:16 a.m.
How femtech is helping fibromyalgia patients - FemTech World

How femtech is helping fibromyalgia patients FemTech World

Published: June 17, 2026, 11:26 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - beQuoted

Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat beQuoted

Published: June 17, 2026, 9 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - The Manila Times

Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat The Manila Times

Published: June 17, 2026, 8:29 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - Yahoo Finance Singapore

Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat Yahoo Finance Singapore

Published: June 17, 2026, 8:05 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - Dagens industri

Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat Dagens industri

Published: June 17, 2026, 7:01 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - Cision News

Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat Cision News

Published: June 17, 2026, 7 a.m.
Chronic Cough in Patients with Idiopathic Pulmonary Fibrosis: Burden, Mechanism, and Implications for Treatment - EMJ

Chronic Cough in Patients with Idiopathic Pulmonary Fibrosis: Burden, Mechanism, and Implications for Treatment EMJ

Published: June 16, 2026, 9:15 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!